Local proteins associated with methamphetamine-induced nigrostriatal dopaminergic neurotoxicity

Pao-Chi Liao1, Yu-Min Kuo, Hen-Chia Hsu

  • 1Department of Environmental and Occupational Health, National Cheng Kung University College of Medicine, Tainan, Taiwan.

Journal of Neurochemistry
|September 27, 2005
PubMed

Insights

Methamphetamine (MA) neurotoxicity involves local protein synthesis, with alpha-synuclein up-regulation and ubiquitin carboxy-terminal hydrolase/PGP 9.5 down-regulation linked to dopaminergic damage.

Area of Science:

  • Neuroscience
  • Proteomics
  • Neuropharmacology

Background:

  • Methamphetamine (MA) causes nigrostriatal dopaminergic toxicity.
  • Local protein synthesis plays a role in this neurotoxicity.

Purpose of the Study:

  • To identify proteins involved in MA-induced dopaminergic neurotoxicity.
  • To elucidate the mechanism of MA neurotoxicity.

Main Methods:

  • Proteomic analysis using two-dimensional gel electrophoresis (2-DE) and mass spectrometry.
  • Inhibition of local protein synthesis with anisomycin.
  • Western blotting to confirm protein expression changes.

Main Results:

  • MA treatment altered the expression of nine protein spots in striatal samples.
  • Alpha-synuclein was up-regulated, while ATPase, F-actin capping protein beta subunit, ubiquitin carboxy-terminal hydrolase/PGP 9.5, and peroxidase were down-regulated.
  • Anisomycin abolished MA-induced dopamine and DOPAC depletions, indicating a role for local protein synthesis.

Conclusions:

  • Local up-regulation of alpha-synuclein and down-regulation of ubiquitin carboxy-terminal hydrolase/PGP 9.5 are associated with MA-induced dopaminergic terminal toxicity.
  • Local protein synthesis blockade reverses MA neurotoxicity through a temperature-independent mechanism.